Canigen LR vakcina A.U.V.
Canigen LR vakcina A.U.V.
Authorised
- Leptospira interrogans, serogroup Canicola, serovar Canicola, strain 601903, Inactivated
- Rabies virus, Inactivated
- Leptospira interrogans, serovar Icterohaemorrhagiae, strain 601895, Inactivated
Product identification
Medicine name:
Canigen LR vakcina A.U.V.
Active substance:
- Leptospira interrogans, serogroup Canicola, serovar Canicola, strain 601903, Inactivated
- Rabies virus, Inactivated
- Leptospira interrogans, serovar Icterohaemorrhagiae, strain 601895, Inactivated
Target species:
-
Dog
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
Leptospira interrogans, serogroup Canicola, serovar Canicola, strain 601903, Inactivated800.00/million cells1.00unit(s)/dose
-
Rabies virus, Inactivated1.00/international unit(s)1.00unit(s)/dose
-
Leptospira interrogans, serovar Icterohaemorrhagiae, strain 601895, Inactivated800.00/million cells1.00unit(s)/dose
Pharmaceutical form:
-
Suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AL01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Hungary
Package description:
- Available only in Hungarian
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
- Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
- Virbac
Responsible authority:
- Directorate Of Veterinary Medicinal Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
